Home NDC 61958-2902 Veklury
Product NDC 61958-2902
11-digit product format 619582902
Labeler code 61958
Product ID 61958-2902_da7319f5-e412-4afd-8456-369cb3a39a1f
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name remdesivir
Dosage form INJECTION
Route INTRAVENOUS
Labeler Gilead Sciences, Inc.
Application NDA214787
Marketing category NDA
Marketing start 2022-03-25
Marketing end 0000-00-00
Substance REMDESIVIR
Active strength 5 mg/mL
Pharmacologic classes SARS-CoV-2 Nucleotide Analog RNA Polymerase Inhibitor [EPC]
NDC exclude flag No
Listing certified through 2023-12-31
Current FDA listing Historical FDA.report record Observed NDC auxiliary status history# This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
Historic NDC status page 1 of 1 · 26 matching rows.
View current auxiliary records. · View the auxiliary file history.
Captured / source date, Dataset, Scope table Captured / source date Dataset Scope Package NDC Snapshot Source SHA-256 2025-12-14 17:58 UTC · source 2025-12-05 excluded product product d630ba8d3edf…732f749b63fb…2025-12-14 17:58 UTC · source 2025-12-05 excluded product product d630ba8d3edf…732f749b63fb…2025-12-14 17:58 UTC · source 2025-12-05 excluded package package 61958-2902-1 d630ba8d3edf…732f749b63fb…2025-12-14 17:58 UTC · source 2025-12-05 excluded package package 61958-2902-2 d630ba8d3edf…732f749b63fb…2025-08-27 00:01 UTC · source 2025-08-26 excluded product product f5e01cc5f278…a2eaf40c39c3…2025-08-27 00:01 UTC · source 2025-08-26 excluded package package 61958-2902-1 f5e01cc5f278…a2eaf40c39c3…2025-04-01 02:39 UTC · source 2025-03-31 excluded product product 2ef7874e63bc…57b86245f4fa…2025-04-01 02:39 UTC · source 2025-03-31 excluded package package 61958-2902-1 2ef7874e63bc…57b86245f4fa…2025-03-28 20:22 UTC · source 2025-03-28 excluded product product a1b67e2a42f9…c4cf2c586c0d…2025-03-28 20:22 UTC · source 2025-03-28 excluded package package 61958-2902-1 a1b67e2a42f9…c4cf2c586c0d…2025-03-22 03:12 UTC · source 2025-03-21 excluded product product cfe11265f3b6…090c488252e2…2025-03-22 03:12 UTC · source 2025-03-21 excluded package package 61958-2902-1 cfe11265f3b6…090c488252e2…2025-03-10 12:48 UTC · source 2025-03-10 excluded product product cdf11ea48f46…ba0047e9e063…2025-03-10 12:48 UTC · source 2025-03-10 excluded package package 61958-2902-1 cdf11ea48f46…ba0047e9e063…2025-02-02 03:52 UTC · source 2025-01-31 excluded product product 302b2466d912…e7b80fea0513…2025-02-02 03:52 UTC · source 2025-01-31 excluded package package 61958-2902-1 302b2466d912…e7b80fea0513…2025-01-20 13:05 UTC · source 2025-01-20 excluded product product ed331223b511…672a5bd82f5f…2025-01-20 13:05 UTC · source 2025-01-20 excluded package package 61958-2902-1 ed331223b511…672a5bd82f5f…2025-01-11 03:41 UTC · source 2025-01-10 excluded product product 0efc9e666f02…f202fb6c5f17…2025-01-11 03:41 UTC · source 2025-01-10 excluded package package 61958-2902-1 0efc9e666f02…f202fb6c5f17…2024-11-09 02:27 UTC · source 2024-11-08 excluded product product ad56d346431e…cc804d4bbf1e…2024-11-09 02:27 UTC · source 2024-11-08 excluded package package 61958-2902-1 ad56d346431e…cc804d4bbf1e…2024-10-04 04:10 UTC · source 2024-10-03 excluded product product 367a005e9d99…383a685ebd0f…2024-10-04 04:10 UTC · source 2024-10-03 excluded package package 61958-2902-1 367a005e9d99…383a685ebd0f…2024-07-10 04:00 UTC · source 2024-07-09 excluded product product 557ba5c1ecfa…9c80585c8c6e…2024-07-10 04:00 UTC · source 2024-07-09 excluded package package 61958-2902-1 557ba5c1ecfa…9c80585c8c6e…
Source provenance: Browse the complete Orange Book source catalog · source snapshot 1 .
Orange Book products# Current product rows page 1 of 1 · 2 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N214787-001 VEKLURY REMDESIVIR 100MG/VIAL POWDER / INTRAVENOUS RLD, RS 2020-10-22 N214787-002 VEKLURY REMDESIVIR 100MG/20ML (5MG/ML) SOLUTION / INTRAVENOUS RLD 2020-10-22
Orange Book patents# Current patent rows page 1 of 1 · 71 matching rows.
Application-product, Patent, Expiration table Application-product Patent Expiration Use code Coverage / status Submission date N214787-001 8318682 2029-04-22 Drug substance, Drug product 2020-11-12 N214787-001 RE46762 2029-04-22 Drug substance, Drug product 2020-11-12 N214787-001 8008264 2029-09-06 Drug substance, Drug product 2020-11-12 N214787-001 8318682*PED 2029-10-22 Pediatric extension N214787-001 RE46762*PED 2029-10-22 Pediatric extension N214787-001 8008264*PED 2030-03-06 Pediatric extension N214787-001 10065958 2031-09-16 Drug substance 2020-11-12 N214787-001 11492353 2031-12-08 Drug substance 2022-12-06 N214787-001 10065958*PED 2032-03-16 Pediatric extension N214787-001 11492353*PED 2032-06-08 Pediatric extension N214787-001 9724360 2035-10-29 Drug substance, Drug product 2020-11-12 N214787-001 9949994 2035-10-29 Drug substance 2020-11-12 N214787-001 9724360*PED 2036-04-29 Pediatric extension N214787-001 9949994*PED 2036-04-29 Pediatric extension N214787-001 10695361 2036-09-16 U-3831 2020-11-12 N214787-001 10695361 2036-09-16 U-3832 2020-11-12 N214787-001 11007208 2036-09-16 U-3831 2021-06-15 N214787-001 11007208 2036-09-16 U-3832 2021-06-15 N214787-001 11382926 2036-09-16 U-3831 2022-08-02 N214787-001 11382926 2036-09-16 U-3832 2022-08-02 N214787-001 10695361*PED 2037-03-16 Pediatric extension N214787-001 11007208*PED 2037-03-16 Pediatric extension N214787-001 11382926*PED 2037-03-16 Pediatric extension N214787-001 10675296 2038-07-10 Drug product 2020-11-12 N214787-001 11266681 2038-07-10 U-3831 2022-04-04 N214787-001 11266681 2038-07-10 U-3832 2022-04-04 N214787-001 11975017 2038-07-10 Drug product 2024-06-05 N214787-001 10675296*PED 2039-01-10 Pediatric extension N214787-001 11266681*PED 2039-01-10 Pediatric extension N214787-001 11975017*PED 2039-01-10 Pediatric extension N214787-001 11491169 2041-05-28 U-3835 2022-12-06 N214787-001 11491169 2041-05-28 U-3836 2022-12-06 N214787-001 11903953 2041-05-28 U-3835 2024-03-19 N214787-001 11903953 2041-05-28 U-3836 2024-03-19 N214787-001 11975012 2041-05-28 U-3835 2024-06-05 N214787-001 11975012 2041-05-28 U-3836 2024-06-05 N214787-001 11491169*PED 2041-11-28 Pediatric extension N214787-001 11903953*PED 2041-11-28 Pediatric extension N214787-001 11975012*PED 2041-11-28 Pediatric extension N214787-002 8318682 2029-04-22 Drug substance, Drug product 2020-11-12 N214787-002 RE46762 2029-04-22 Drug substance, Drug product 2020-11-12 N214787-002 8008264 2029-09-06 Drug substance, Drug product 2020-11-12 N214787-002 8318682*PED 2029-10-22 Pediatric extension N214787-002 RE46762*PED 2029-10-22 Pediatric extension N214787-002 8008264*PED 2030-03-06 Pediatric extension N214787-002 10065958 2031-09-16 Drug substance 2020-11-12 N214787-002 11492353 2031-12-08 Drug substance 2022-12-06 N214787-002 10065958*PED 2032-03-16 Pediatric extension N214787-002 11492353*PED 2032-06-08 Pediatric extension N214787-002 9724360 2035-10-29 Drug substance, Drug product 2020-11-12 N214787-002 9949994 2035-10-29 Drug substance 2020-11-12 N214787-002 9724360*PED 2036-04-29 Pediatric extension N214787-002 9949994*PED 2036-04-29 Pediatric extension N214787-002 10695361 2036-09-16 U-3829 2020-11-12 N214787-002 10695361 2036-09-16 U-3830 2020-11-12 N214787-002 11007208 2036-09-16 U-3829 2021-06-15 N214787-002 11007208 2036-09-16 U-3830 2021-06-15 N214787-002 11382926 2036-09-16 U-3829 2022-08-02 N214787-002 11382926 2036-09-16 U-3830 2022-08-02 N214787-002 10695361*PED 2037-03-16 Pediatric extension N214787-002 11007208*PED 2037-03-16 Pediatric extension N214787-002 11382926*PED 2037-03-16 Pediatric extension N214787-002 11491169 2041-05-28 U-3833 2022-12-06 N214787-002 11491169 2041-05-28 U-3834 2022-12-06 N214787-002 11903953 2041-05-28 U-3833 2024-03-19 N214787-002 11903953 2041-05-28 U-3834 2024-03-19 N214787-002 11975012 2041-05-28 U-3833 2024-06-05 N214787-002 11975012 2041-05-28 U-3834 2024-06-05 N214787-002 11491169*PED 2041-11-28 Pediatric extension N214787-002 11903953*PED 2041-11-28 Pediatric extension N214787-002 11975012*PED 2041-11-28 Pediatric extension
Orange Book exclusivity# Current exclusivity rows page 1 of 1 · 8 matching rows.
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 2 · 72 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-02-19 14:30 UTC 2026-02 N214787-001 VEKLURY 100MG/VIAL POWDER / INTRAVENOUS RLD, RS 2020-10-22 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N214787-002 VEKLURY 100MG/20ML (5MG/ML) SOLUTION / INTRAVENOUS RLD 2020-10-22 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N214787-001 VEKLURY 100MG/VIAL POWDER / INTRAVENOUS RLD, RS 2020-10-22 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N214787-002 VEKLURY 100MG/20ML (5MG/ML) SOLUTION / INTRAVENOUS RLD 2020-10-22 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N214787-001 VEKLURY 100MG/VIAL POWDER / INTRAVENOUS RLD, RS 2020-10-22 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N214787-002 VEKLURY 100MG/20ML (5MG/ML) SOLUTION / INTRAVENOUS RLD 2020-10-22 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N214787-001 VEKLURY 100MG/VIAL POWDER / INTRAVENOUS RLD, RS 2020-10-22 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N214787-002 VEKLURY 100MG/20ML (5MG/ML) SOLUTION / INTRAVENOUS RLD, RS 2020-10-22 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N214787-001 VEKLURY 100MG/VIAL POWDER / INTRAVENOUS RLD, RS 2020-10-22 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N214787-002 VEKLURY 100MG/20ML (5MG/ML) SOLUTION / INTRAVENOUS RLD, RS 2020-10-22 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N214787-001 VEKLURY 100MG/VIAL POWDER / INTRAVENOUS RLD, RS 2020-10-22 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N214787-002 VEKLURY 100MG/20ML (5MG/ML) SOLUTION / INTRAVENOUS RLD, RS 2020-10-22 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N214787-001 VEKLURY 100MG/VIAL POWDER / INTRAVENOUS RLD, RS 2020-10-22 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N214787-002 VEKLURY 100MG/20ML (5MG/ML) SOLUTION / INTRAVENOUS RLD, RS 2020-10-22 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N214787-001 VEKLURY 100MG/VIAL POWDER / INTRAVENOUS RLD, RS 2020-10-22 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N214787-002 VEKLURY 100MG/20ML (5MG/ML) SOLUTION / INTRAVENOUS RLD, RS 2020-10-22 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N214787-001 VEKLURY 100MG/VIAL POWDER / INTRAVENOUS RLD, RS 2020-10-22 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N214787-002 VEKLURY 100MG/20ML (5MG/ML) SOLUTION / INTRAVENOUS RLD, RS 2020-10-22 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 N214787-001 VEKLURY 100MG/VIAL POWDER / INTRAVENOUS RLD, RS 2020-10-22 d06236e962d9…2024-10-29 15:01 UTC 2024-10 N214787-002 VEKLURY 100MG/20ML (5MG/ML) SOLUTION / INTRAVENOUS RLD, RS 2020-10-22 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N214787-001 VEKLURY 100MG/VIAL POWDER / INTRAVENOUS RLD, RS 2020-10-22 79d66fd596c7…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N214787-002 VEKLURY 100MG/20ML (5MG/ML) SOLUTION / INTRAVENOUS RLD, RS 2020-10-22 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 N214787-001 VEKLURY 100MG/VIAL POWDER / INTRAVENOUS RLD, RS 2020-10-22 301d65b070ca…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 N214787-002 VEKLURY 100MG/20ML (5MG/ML) SOLUTION / INTRAVENOUS RLD, RS 2020-10-22 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 N214787-001 VEKLURY 100MG/VIAL POWDER / INTRAVENOUS RLD, RS 2020-10-22 1e350fbaab3a…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 N214787-002 VEKLURY 100MG/20ML (5MG/ML) SOLUTION / INTRAVENOUS RLD, RS 2020-10-22 1e350fbaab3a…2024-05-31 18:47 UTC 2024-05 N214787-001 VEKLURY 100MG/VIAL POWDER / INTRAVENOUS RLD, RS 2020-10-22 8072bd15b7f6…2024-05-31 18:47 UTC 2024-05 N214787-002 VEKLURY 100MG/20ML (5MG/ML) SOLUTION / INTRAVENOUS RLD, RS 2020-10-22 8072bd15b7f6…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 N214787-001 VEKLURY 100MG/VIAL POWDER / INTRAVENOUS RLD, RS 2020-10-22 5c6f7cd8ea54…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 N214787-002 VEKLURY 100MG/20ML (5MG/ML) SOLUTION / INTRAVENOUS RLD, RS 2020-10-22 5c6f7cd8ea54…2022-04-08 23:34 UTC 2022-04 N214787-001 VEKLURY 100MG/VIAL POWDER / INTRAVENOUS RLD, RS 2020-10-22 5d02ea3f76ae…2022-04-08 23:34 UTC 2022-04 N214787-002 VEKLURY 100MG/20ML (5MG/ML) SOLUTION / INTRAVENOUS RLD, RS 2020-10-22 5d02ea3f76ae…2022-04-04 05:41 UTC 2022-04 N214787-001 VEKLURY 100MG/VIAL POWDER / INTRAVENOUS RLD, RS 2020-10-22 4b0b4de00fa7…2022-04-04 05:41 UTC 2022-04 N214787-002 VEKLURY 100MG/20ML (5MG/ML) SOLUTION / INTRAVENOUS RLD, RS 2020-10-22 4b0b4de00fa7…2022-03-09 01:35 UTC 2022-03 N214787-001 VEKLURY 100MG/VIAL POWDER / INTRAVENOUS RLD, RS 2020-10-22 bb7c543d1eb4…2022-03-09 01:35 UTC 2022-03 N214787-002 VEKLURY 100MG/20ML (5MG/ML) SOLUTION / INTRAVENOUS RLD, RS 2020-10-22 bb7c543d1eb4…2021-12-28 21:50 UTC 2021-12 N214787-001 VEKLURY 100MG/VIAL POWDER / INTRAVENOUS RLD, RS 2020-10-22 782e0a99824c…2021-12-28 21:50 UTC 2021-12 N214787-002 VEKLURY 100MG/20ML (5MG/ML) SOLUTION / INTRAVENOUS RLD, RS 2020-10-22 782e0a99824c…2021-05-05 16:15 UTC · 3 captures of this ZIP 2021-05 N214787-001 VEKLURY 100MG/VIAL POWDER / INTRAVENOUS RLD, RS 2020-10-22 87673890dc5c…2021-05-05 16:15 UTC · 3 captures of this ZIP 2021-05 N214787-002 VEKLURY 100MG/20ML (5MG/ML) SOLUTION / INTRAVENOUS RLD, RS 2020-10-22 87673890dc5c…
Observed Orange Book patent history# Patent history page 1 of 47 · 1,872 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Patent Expiration Use code Coverage / status Submission date Source SHA-256 2026-02-19 14:30 UTC 2026-02 N214787-001 8318682 2029-04-22 Drug substance, Drug product 2020-11-12 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N214787-001 RE46762 2029-04-22 Drug substance, Drug product 2020-11-12 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N214787-001 8008264 2029-09-06 Drug substance, Drug product 2020-11-12 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N214787-001 8318682*PED 2029-10-22 Pediatric extension 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N214787-001 RE46762*PED 2029-10-22 Pediatric extension 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N214787-001 8008264*PED 2030-03-06 Pediatric extension 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N214787-001 10065958 2031-09-16 Drug substance 2020-11-12 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N214787-001 11492353 2031-12-08 Drug substance 2022-12-06 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N214787-001 10065958*PED 2032-03-16 Pediatric extension 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N214787-001 11492353*PED 2032-06-08 Pediatric extension 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N214787-001 9724360 2035-10-29 Drug substance, Drug product 2020-11-12 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N214787-001 9949994 2035-10-29 Drug substance 2020-11-12 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N214787-001 9724360*PED 2036-04-29 Pediatric extension 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N214787-001 9949994*PED 2036-04-29 Pediatric extension 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N214787-001 10695361 2036-09-16 U-3831 2020-11-12 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N214787-001 10695361 2036-09-16 U-3832 2020-11-12 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N214787-001 11007208 2036-09-16 U-3831 2021-06-15 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N214787-001 11007208 2036-09-16 U-3832 2021-06-15 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N214787-001 11382926 2036-09-16 U-3831 2022-08-02 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N214787-001 11382926 2036-09-16 U-3832 2022-08-02 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N214787-001 10695361*PED 2037-03-16 Pediatric extension 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N214787-001 11007208*PED 2037-03-16 Pediatric extension 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N214787-001 11382926*PED 2037-03-16 Pediatric extension 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N214787-001 10675296 2038-07-10 Drug product 2020-11-12 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N214787-001 11266681 2038-07-10 U-3832 2022-04-04 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N214787-001 11266681 2038-07-10 U-3831 2022-04-04 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N214787-001 11975017 2038-07-10 Drug product 2024-06-05 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N214787-001 10675296*PED 2039-01-10 Pediatric extension 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N214787-001 11266681*PED 2039-01-10 Pediatric extension 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N214787-001 11975017*PED 2039-01-10 Pediatric extension 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N214787-001 11491169 2041-05-28 U-3836 2022-12-06 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N214787-001 11491169 2041-05-28 U-3835 2022-12-06 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N214787-001 11903953 2041-05-28 U-3835 2024-03-19 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N214787-001 11903953 2041-05-28 U-3836 2024-03-19 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N214787-001 11975012 2041-05-28 U-3835 2024-06-05 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N214787-001 11975012 2041-05-28 U-3836 2024-06-05 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N214787-001 11491169*PED 2041-11-28 Pediatric extension 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N214787-001 11903953*PED 2041-11-28 Pediatric extension 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N214787-001 11975012*PED 2041-11-28 Pediatric extension 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N214787-002 8318682 2029-04-22 Drug substance, Drug product 2020-11-12 011fe1cb6892…
Observed Orange Book exclusivity history# Exclusivity history page 1 of 9 · 352 observed states.
DailyMed Product Concepts# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 61958-2902-2 Veklury 1 in 1 CARTON INJECTION 1 23 61958-2902-2 Veklury 20 mL in 1 VIAL, SINGLE-DOSE INJECTION 20 23
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 61958-2902 VEKLURY (REMDESIVIR) INJECTION VEKLURY (REMDESIVIR) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [GILEAD SCIENCES, INC.] 20 Legacy NDC, 2 package rows 20250126_c0978fa8-53ff-4ca2-82a7-567fd3e958ca.zip
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Marketing start Marketing end Sample Exclude flag Status 61958-2902-1 61958290201 1 VIAL, SINGLE-DOSE in 1 CARTON (61958-2902-1) > 20 mL in 1 VIAL, SINGLE-DOSE 2020-05-01 2022-08-31 No No Current 61958-2902-2 61958290202 1 VIAL, SINGLE-DOSE in 1 CARTON (61958-2902-2) > 20 mL in 1 VIAL, SINGLE-DOSE 2021-09-01 0000-00-00 No No Current